Notably, emerging evidence from pluripotent stem cell models indicates that PRPS1/2‐mediated purine biosynthesis serves as a critical metabolic switch governing the balance between stemness maintenance and differentiation [9], suggesting potential conserved mechanisms in MYCN‐driven NB. This evidence concerns the gene MYCN and neuroblastoma.